Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14 cyclopia sequence 7 Prostatic Neoplasms 6 Neoplasms 6 Polycystic Ovary Syndrome 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Head and Neck Neoplasms 3 Fatigue 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leiomyoma 2 Insulin Resistance 2 Infertility 2 Hematologic Diseases 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1 Warts 1 Vitamin D Deficiency 1

Interventions

efgartigimod alfa 10 rozanolixizumab 9 Prednisone 8 zilucoplan 7 Pyridostigmine Bromide 7 Cyclophosphamide 7 telitacicept 6 Tacrolimus 6 Rituximab 6 ravulizumab 5 fludarabine 5 eculizumab 5 Mycophenolic Acid 4 Hizentra 4 Steroids 3 Immunoglobulins, Intravenous 3 HBM9161 3 Data Collection 3 Azathioprine 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Blood Specimen Collection 2 tofacitinib 1 tocilizumab 1 satralizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡